Education
About Us
Working with TipRanks
Follow Us
Sanjiv Patel Insider Profile
4 Followers
Sanjiv Patel, President & CEO, Director at Relay Therapeutics, holds 1.59M shares in Relay Therapeutics (Ticker: RLAY), holds ― shares in Prothena (Ticker: PRTA). Most recently, Sanjiv Patel Sold ― shares of Relay Therapeutics on Nov 04, 2025 for an estimated value of $434.51K.
Sanjiv Patel Relay Therapeutics (RLAY)President & CEO, Director
Relay Therapeutics (RLAY)
President & CEO, Director
Ranked #98,784 out of 104,104 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-72.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sanjiv Patel holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sanjiv Patel
Sanjiv Patel's Trading History
Relay Therapeutics
Nov 04, 2025
President & CEO, Director
Informative Sell
434.51K
$10.38M
Prothena
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Sanjiv Patel's performance on stock
You May Also Like
Sanjiv Patel insider profile FAQ
What is the percentage of profitable transactions made by Sanjiv Patel?
The percentage of profitable transactions made by Sanjiv Patel is 0%.
What is the average return per transaction made by Sanjiv Patel?
The average return per transaction made by Sanjiv Patel is -72.10%.
What stocks does Sanjiv Patel hold?
Sanjiv Patel holds: RLAY, PRTA stocks.
What was Sanjiv Patel’s latest transaction?
Sanjiv Patel latest transaction was an Informative Sell of $434.51K.
What was Sanjiv Patel's most profitable transaction?
Sanjiv Patel’s most profitable transaction was an Informative Buy of RLAY stock on July 21, 2020. The return on the trade was -16.40%.
What is Sanjiv Patel's role in Relay Therapeutics?
Sanjiv Patel's role in Relay Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.